Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...

Eli Lilly headquarters in Indianapolis. Pharmaceutical giant Eli Lilly (LLY) is putting $4.5 billion toward building a new site to develop and manufacture drugs. The Lilly Medicine Foundry ...

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased a 323,930-square-foot industrial building in the ...

Eli Lilly and Co. plans to set up a $31 million digital health innovation hub in Singapore, expanding its research and ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

and this research and development site will do that work," Eli Lilly Chief Executive Officer David Ricks said in an interview from the company's headquarters in Indianapolis. The center ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Lilly (NYSE: LLY) makes drugs including Mounjaro for type 2 diabetes and Zepbound for obesity. For 2023, it reported $34 ...

Eli Lilly said on Monday it sued three medical ... and misleading consumers about the clinical data used to back them. The Indianapolis-based drugmaker has already sued more than two dozen ...

Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading pharmaceutical company that sells Trulicity, Verzenio, and Taltz drugs. The company discovers, develops, and markets human ...

Eli Lilly and Company Stock Up 0.3 % Shares of NYSE LLY opened at $909.15 on Wednesday. The firm’s 50-day moving average price is $921.67 and its 200-day moving average price is $860.45. The ...